Review
Open access
Oct 2026
Recent advances in antituberculosis drugs and therapeutics: from mechanistic breakthroughs to clinical translation
Tuberculosis (TB), caused by Mycobacterium tuberculosis, reclaimed its status as the deadliest single-pathogen infectious disease globally in 2023, accounting for 10.8 million new cases and 1.25 million deaths in 2023. The escalating crisis of drug-resistant TB, suboptimal BCG vaccine efficacy in adults, and persistent...
Zhi-Xiang Pan, Guan Liu, Yue-Hua Li et al.
· Molecular Biomedicine · 0 citations